U.S. market Closed. Opens in 1 day 3 hours 51 minutes

EBS | Emergent BioSolutions Inc. Stock Financials Income Statements Annual

(Stock Exchange: NYSE)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-31
Revenue1.05B1.12B1.79B1.56B1.11B782.40M560.87M488.78M522.79M450.14M312.75M281.89M273.38M286.17M234.79M178.55M182.91M152.73M130.69M83.49M55.77M78.54M45.31M
Cost of Revenue705.40M693.70M757.50M524.00M433.50M322.30M195.71M131.28M124.30M118.41M62.13M46.08M42.17M47.11M46.26M34.08M40.31M24.12M31.60M30.10MN/A24.57M424.10M
Gross Profit343.90M427.20M1.04B1.03B672.50M460.10M365.17M357.50M398.49M331.73M250.62M235.81M231.21M239.06M188.52M144.47M142.61M128.61M99.08M53.39M55.77M53.97M-378.79M
Operating Expenses1.04B593.20M640.90M597.60M558.40M370.30M240.88M251.98M302.45M273.67M207.82M196.24M199.11M165.50M148.37M114.55M109.51M90.10M51.17M40.44MN/A16.20M869.50M
Selling, General & Admin368.40M340.30M348.40M303.30M273.50M202.50M143.50M143.69M148.46M122.84M87.88M76.02M74.28M76.20M73.79M55.08M55.55M44.60M42.79M30.32MN/A13.40M340.30M
Research & Development111.40M193.00M234.00M234.50M226.20M142.80M97.38M108.29M154.00M150.83M119.93M120.23M124.83M89.30M74.59M59.47M53.96M45.50M18.38M10.12MN/A2.81M193.00M
Other Operating Expenses564.20M59.90M58.50M59.80M58.70M1.60M-815.00K263.00K-319.00K2.93M426.00K1.97MN/AN/AN/AN/AN/A16.57M-10.00MN/AN/AN/A336.20M
Operating Income-726.40M-166.00M352.60M433.80M114.10M89.80M124.28M105.52M96.04M58.06M42.80M29.97M32.10M73.56M40.15M29.93M33.09M38.03M21.34M16.77M55.77M37.77M-364.00K
Other Expenses / Income-4.80M-53.00M-38.20M-26.60M-36.70M-8.30M-5.70M-6.30M-5.80M-4.99M565.00K2.10M-156.00K-191.00K1.36M2.09M2.89M-490.00K-16.80M-170.00K-55.77M-642.00K-190.00K
Before Tax Income-731.20M-221.70M314.40M407.20M77.40M81.50M118.63M99.22M89.77M53.06M43.37M32.06M31.94M73.37M41.51M32.74M35.99M38.02M21.11M16.60MN/A37.12M-554.00K
Income Tax Expenses29.30M2.10M83.50M102.10M22.90M18.80M36.04M36.70M26.90M16.32M13.11M13.92M15.83M26.18M14.97M12.05M13.05M15.22M5.33M5.13M-4.45M733.00K2.10M
Net Income-760.50M-223.80M219.50M305.80M54.50M62.70M82.59M51.78M62.87M36.74M31.14M23.52M23.02M51.70M31.14M20.68M22.94M22.79M15.78M11.47M4.45M36.39M-554.00K
Interest Expenses87.90M37.30M34.50M31.30M38.40M9.90M6.59M7.62M6.52M8.24MN/A6.00KN/AN/A7.00K47.00KN/AN/AN/AN/AN/AN/AN/A
Basic Shares Outstanding51.20M50.10M53.50M52.70M51.50M50.10M41.82M40.18M38.60M37.34M36.20M36.08M35.66M31.78M30.44M29.84M29.00M23.04M20.53M18.92M18.90M18.47M18.47M
Diluted Shares Outstanding51.20M50.10M54.10M53.80M52.40M51.40M50.33M49.34M47.26M45.80M36.75M36.42M36.21M32.54M31.38M30.46M29.66M24.57M22.75M20.44M20.32M20.80M18.47M
EBITDA-505.30M-32.90M458.20M549.00M227.30M152.70M158.13M145.07M177.57M93.75M62.33M43.27M41.30M79.36M46.52M37.02M37.91M43.88M25.43M18.71M55.77M37.77M45.31M
EBITDA Margin-48.16%-2.94%25.56%35.30%20.55%19.52%28.19%29.68%33.97%20.83%19.93%15.35%15.11%27.73%19.81%20.74%20.73%28.73%19.45%22.41%100.00%48.09%100.00%
EBIT-643.30M-184.40M337.50M439.20M115.80M91.40M125.22M96.09M96.29M61.30M44.24M37.45M38.85M77.88M46.12M32.78M35.99M38.02M21.11M16.60MN/A37.12M1.55M
EBIT Margin-61.31%-16.45%18.83%28.24%10.47%11.68%22.33%19.66%18.42%13.62%14.15%13.29%14.21%27.21%19.64%18.36%19.67%24.89%16.15%19.88%0.00%47.27%3.41%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙